Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

H2R8H3 (H2R8H3_PANTR) Pan troglodytes (Chimpanzee)

Protein cereblon UniProtKBInterProInteractive Modelling

442 aa; Sequence (Fasta) ; 3 identical sequences: Homo sapiens: Q96SW2; Pan troglodytes: A0A6D2W501; Pan paniscus: A0A2R9CKP4

Available Structures

36 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure of the DDB1-CRBN-pomalidomide complex bound to ZNF692(ZF4) Heteromer
Q16531; Q96SW2; Q9BU19;
42-442
ZN;Y70;
Assess
Crystal structure of human CRBN-DDB1 in complex with Pomalidomide Heteromer
Q16531; Q96SW2;
44-442
EDO;ZN;Y70;
Assess
Cereblon in complex with DDB1, CC-90009, and GSPT1 Heteromer
P15170; Q16531; Q96SW2;
46-442
V4M;ZN;
Assess
Cereblon in complex with DDB1, CC-885, and GSPT1 Heteromer
P15170; Q16531; Q96SW2;
48-442
ZN;85C;
Assess
Structural basis of Lenalidomide induced CK1a degradation by the crl4crbn ubiquitin ligase Heteromer
P48729; Q16531; Q96SW2;
47-436
ZN;LVY;
Assess
Crystal structure of DDB1-CRBN-ALV1 complex bound to Helios (IKZF2 ZF2) Heteromer
Q16531; Q96SW2; Q9UKS7;
47-436
ZN;RN9;
Assess
Crystal structure of human CRBN-DDB1 in complex with compound 4 Heteromer
Q16531; Q96SW2;
44-428
EDO;ZN;VP9;
Assess
Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET6 PROTAC. Heteromer
O60885; Q16531; Q96SW2;
44-427
ZN;RN6;
Assess
Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET23 PROTAC. Heteromer
O60885; Q16531; Q96SW2;
44-427
ZN;RN3;
Assess
Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET70 PROTAC Heteromer
O60885; Q16531; Q96SW2;
44-427
ZN;
Assess
Cereblon~DDB1 bound to CC-92480 with DDB1 in the hinged conformation Heteromer
Q16531; Q96SW2;
42-425
ZN;QFC;
Assess
Cereblon~DDB1 bound to CC-92480 with DDB1 in the linear conformation Heteromer
Q16531; Q96SW2;
42-425
ZN;QFC;
Assess
Cereblon~DDB1 bound to CC-92480 with DDB1 in the twisted conformation Heteromer
Q16531; Q96SW2;
42-425
ZN;QFC;
Assess
Cryo-EM structure of DDB1dB:CRBN:PT-179:SD40, conformation 2 Heteromer
Q13422; Q16531; Q96SW2;
44-427
ZN;MIQ;
Assess
Cereblon in complex with DDB1 and CC-220 Heteromer
Q16531; Q96SW2;
47-428
8W7;ZN;
Assess
Structure with SJ3149 Heteromer
P48729; Q16531; Q96SW2;
47-428
ZN;YOT;
Assess
Crystal Structure of Human Cereblon in Complex with DDB1 and Lenalidomide Heteromer
Q16531; Q96SW2;
48-428
ZN;LVY;
Assess
Cereblon~DDB1 bound to Iberdomide and Ikaros ZF1-2-3 Heteromer
Q13422; Q16531; Q96SW2;
45-425
ZN;8W7;
Assess
Cereblon-DDB1 bound to CC-92480 and Ikaros ZF1-2-3 Heteromer
Q13422; Q16531; Q96SW2;
45-425
ZN;QFC;
Assess
Cereblon~DDB1 bound to Pomalidomide Heteromer
Q16531; Q96SW2;
45-425
ZN;Y70;
Assess
Structural Basis for Thalidomide Teratogenicity Revealed by the Cereblon-DDB1-SALL4-Pomalidomide Co… Heteromer
Q16531; Q96SW2; Q9UJQ4;
48-427
ZN;Y70;
Assess
Cryo-EM structure of DDB1dB:CRBN:PT-179:SD40, conformation 1 Heteromer
Q13422; Q16531; Q96SW2;
50-427
ZN;MIQ;
Assess
Ternary complex structure of Cereblon-DDB1 bound to IKZF2(ZF2) and the molecular glue DKY709 Heteromer
Q16531; Q53SU9; Q96SW2;
69-442
ZN;LWK;SO4;
Assess
Structure of DDB1-CRBN-pomalidomide complex bound to IKZF1(ZF2) Heteromer
Q13422; Q16531; Q96SW2;
69-442
ZN;Y70;
Assess
Ternary complex structure of Cereblon-DDB1 bound to IKZF2(ZF2,3) and the molecular glue DKY709 Heteromer
Q16531; Q96SW2; Q9UKS7;
71-442
ZN;LWK;
Assess
The ternary complex structure of DDB1-CRBN-SALL4(ZF1,2)-short bound to CC-220 Heteromer
Q16531; Q96SW2; Q9UJQ4;
72-442
ZN;8W7;SO4;
Assess
Cereblon-DDB1 in the Apo form with DDB1 in the twisted conformation Heteromer
Q16531; Q96SW2;
64-428
ZN;
Assess
Cereblon-DDB1 in the Apo form Heteromer
Q16531; Q96SW2;
64-428
ZN;
Assess
Cereblon~DDB1 in the Apo form with DDB1 in the hinged conformation Heteromer
Q16531; Q96SW2;
64-428
ZN;
Assess
Crystal structure of DDB1-CRBN-BRD4(BD1) complex bound to dBET57 PROTAC Heteromer
O60885; Q16531; Q96SW2;
64-423
ZN;
Assess
The ternary complex structure of DDB1-CRBN-SALL4(ZF1,2)-short bound to Pomalidomide Heteromer
Q16531; Q96SW2; Q9UJQ4;
72-427
ZN;Y70;
Assess
The ternary complex structure of DDB1-CRBN-SALL4(ZF1,2)-long bound to Pomalidomide Heteromer
Q16531; Q96SW2; Q9UJQ4;
72-427
ZN;Y70;
Assess
Cryo-EM structure of DDB1dB:CRBN:Pomalidomide:SD40 Heteromer
Q13422; Q16531; Q96SW2;
77-427
ZN;Y70;
Assess
Cereblon in complex with SALL4 and (S)-5-hydroxythalidomide Heteromer
Q96SW2; Q9UJQ4;
318-426
F4U;ZN;SO4;
Assess
Cereblon in complex with SALL4 and (S)-thalidomide Heteromer
Q96SW2; Q9UJQ4;
318-426
EF2;ZN;
Assess
crystal structure of hN33/Tusc3-peptide 1 Heteromer
Q13454; Q96SW2;
231-236
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6bn7.1.Bmonomer0.8044-427
ZN;99.55
Assess
6bnb.1.Bmonomer0.7264-423
ZN;99.55
Assess